Novartis $2m gene therapy for rare disorder is world’s most expensive drug
নিউ এইজ
প্রকাশিত: ২৬ মে ২০১৯, ০০:০০
Swiss drugmaker Novartis on Friday won US approval for its gene therapy Zolgensma for spinal muscular atrophy (SMA), the leading genetic cause of death in...
